Cited by 861Acute Myocardial Infarction ResearchClinical Laboratory Practices and Quality ControlBiomarkers in Disease Mechanisms

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Analytical Characteristics of High-Sensitivity Cardiac Troponin Assays

Apple, Fred S, Collinson, Paul O, for the IFCC Task Force on Clinical Applications of Cardiac Biomarkers·2012·Clinical Chemistry

DOI 10.1373/clinchem.2011.165795

Open this paper in CoChat — free account

Abstract

BACKGROUND: Cardiac troponins I (cTnI) and T (cTnT) have received international endorsement as the standard biomarkers for detection of myocardial injury, for risk stratification in patients suspected of acute coronary syndrome, and for the diagnosis of myocardial infarction. An evidence-based clinical database is growing rapidly for high-sensitivity (hs) troponin assays. Thus, clarifications of the analytical principles for the immunoassays used in clinical practice are important. CONTENT: The purpose of this mini-review is (a) to provide a background for the biochemistry of cTnT and cTnI and (b) to address the following analytical questions for both hs cTnI and cTnT assays: (i) How does an assay become designated hs? (ii) How does one realistically define healthy (normal) reference populations for determining the 99th percentile? (iii) What is the usual biological variation of these analytes? (iv) What assay imprecision characteristics are acceptable? (v) Will standardization of cardiac troponin assays be attainable? SUMMARY: This review raises important points regarding cTnI and cTnT assays and their reference limits and specifically addresses hs assays used to measure low concentrations (nanograms per liter or picograms per milliliter). Recommendations are made to help clarify the nomenclature. The review also identifies further challenges for the evolving science of cardiac troponin measurement. It is hoped that with the introduction of these concepts, both laboratorians and clinicians can develop a more unified view of how these assays are used worldwide in clinical practice.

Integrity signals

Registry

Crossref · 10.1373/clinchem.2011.165795

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Universal Definition of Myocardial Infarction
Thygesen, K. A., Alpert, J. S., White, H. D., TASK FORCE MEMBERS: Chairpersons: Kristian Thygesen (Denmark), J. S. A. (., Biomarker Group: Allan S. Jaffe, C. (., ECG Group: Bernard Chaitman, C.-O. (., Imaging Group: Richard Underwood, C. (., Intervention Group: Jean-Pierre Bassand, C.-O. (., Mendis, S., Implementation Group: Lars C. Wallentin Coordinator (Sweden), F. F.-A. (., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.187397 · Cited by 4,422
Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction
Thygesen, K. A. (2007) · Circulation · Cited by 3,126
Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction
Task Force Members, Thygesen, K. A., Alpert, J. S., White, H. D., Biomarker Group, Jaffe, A. S., Apple, F. S., Galvani, M., Katus, H. A., Newby, L. K., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm355 · Cited by 2,536
Self-citation
Cardiac troponin I. A marker with high specificity for cardiac injury.
Adams, J. E., Bodor, G. S., Dávila‐Román, V. G., Delmez, J. A., Apple, F. S., Ladenson, J. H., & Jaffe, A. S. (1993) · Circulation · doi:10.1161/01.cir.88.1.101 · Cited by 1,149
Self-citation
Association of Troponin T Detected With a Highly Sensitive Assay and Cardiac Structure and Mortality Risk in the General Population
de Lemos, J. A., Drazner, M. H., Omland, T., Ayers, C. R., Khera, A., Rohatgi, A. K., Hashim, I. A., Berry, J. D., Das, S. R., Morrow, D. A., et al. (2010) · JAMA · doi:10.1001/jama.2010.1768 · Cited by 1,103
Analytical Validation of a High-Sensitivity Cardiac Troponin T Assay
Giannitsis, E., Kurz, K., Hallermayer, K., Jarausch, J., Jaffe, A. S., & Katus, H. A. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.132654 · Cited by 1,087
Association of Serial Measures of Cardiac Troponin T Using a Sensitive Assay With Incident Heart Failure and Cardiovascular Mortality in Older Adults
deFilippi, C. R., de Lemos, J. A., Christenson, R. H., Gottdiener, J. S., Kop, W. J., Zhan, M., & Seliger, S. L. (2010) · JAMA · doi:10.1001/jama.2010.1708 · Cited by 715
Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction
Katus, H. A., Remppis, A. B., Scheffold, T., Diederich, K. W., & Kübler, W. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90466-x · Cited by 557
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes
NACB WRITING GROUP MEMBERS, Morrow, D. A., Cannon, C. P., Jesse, R. L., Newby, L. K., Ravkilde, J., Storrow, A. B., Wu, A. H. B., Christenson, R. H., Christenson, R. H., et al. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.084194 · Cited by 475
Self-citation
Utility of Absolute and Relative Changes in Cardiac Troponin Concentrations in the Early Diagnosis of Acute Myocardial Infarction
Reichlin, T., Irfan, A. B., Twerenbold, R., Reiter, M., Hochholzer, W., Burkhalter, H., Bassetti, S., Steuer, S., Winkler, K., Peter, F., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.023937 · Cited by 459

Flagged first, then by citations

Show all 41 references

Research works printed but not linked: 1

Apple, 2011, Short-term biological variation of cardiac troponin I measured with three high-sensitivity assays [Abstract], Clin Chem, 57, C05

Sorted by citations

Third universal definition of myocardial infarction
the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Thygesen, K., Alpert, J. S., Jaffe, A. S., Simoons, M. L., CHAITMAN, B. R., & White, H. D. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.122 · Cited by 6,585
Third universal definition of myocardial infarction
Thygesen, K. A., Alpert, J. S., Jaffe, A. S., Simoons, M. L., Chaitman, B. R., White, H. D., the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Authors/Task Force Members Chairpersons, Thygesen, K., Alpert, J. S., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs184 · Cited by 3,095
Self-citation
Third Universal Definition of Myocardial Infarction
Thygesen, K., Alpert, J. S., Jaffe, A. S., Simoons, M. L., Chaitman, B. R., & White, H. D. (2012) · Circulation · doi:10.1161/cir.0b013e31826e1058 · Cited by 2,985
Third Universal Definition of Myocardial Infarction
Thygesen, K. A., Alpert, J. S., Jaffe, A. S., Simoons, M. L., CHAITMAN, B. R., White, H. D., Thygesen, K. A., Alpert, J. S., White, H. D., Jaffe, A. S., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.001 · Cited by 2,619
Self-citation
Heart Failure
Braunwald, E. (2013) · JACC Heart Failure · doi:10.1016/j.jchf.2012.10.002 · Cited by 862
How to use high-sensitivity cardiac troponins in acute cardiac care
Thygesen, K. A., Mair, J. M., Giannitsis, E., Mueller, C. E., Lindahl, B., Blankenberg, S., Huber, K., Plebani, M., Biasucci, L. M., Marco Tubaro, U., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs154 · Cited by 781
Self-citation
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
Gulati, G., Heck, S. L., Ree, A. H., Hoffmann, P., Schulz‐Menger, J., Fagerland, M. W., Gravdehaug, B., von Knobelsdorff‐Brenkenhoff, F., Bratland, Å., Storås, T. H., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw022 · Cited by 702
Third Universal Definition of Myocardial Infarction
Thygesen, K. A., Alpert, J. S., Jaffe, A. S., Simoons, M. L., CHAITMAN, B. R., White, H. D., & Writing Group Joint ESC For the Universal Definition of MI (2012) · Global Heart · doi:10.1016/j.gheart.2012.08.001 · Cited by 546
Determination of 19 Cardiac Troponin I and T Assay 99th Percentile Values from a Common Presumably Healthy Population
Apple, F. S., Ler, R., & Murakami, M. M. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.192716 · Cited by 541
Self-citation
High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study
Shah, A. S. V., Anand, A., Sandoval, Y. B., Lee, K. K., Smith, S. W., Adamson, P. D., Chapman, A. R., Langdon, T., Sandeman, D., Vaswani, A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00391-8 · Cited by 521
Self-citation
Cardiac troponins: from myocardial infarction to chronic disease
Park, K. C., Gaze, D. C., Collinson, P. O., & Marber, M. S. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx183 · Cited by 510
Self-citation
High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study
Shah, A. S. V., Griffiths, M., Lee, K. K., McAllister, D., Hunter, A. L., Ferry, A. V., Cruikshank, A., Reid, A. W., Stoddart, M., Strachan, F. E., et al. (2015) · BMJ · doi:10.1136/bmj.g7873 · Cited by 460
Self-citation
Carbon nanotubes as optical biomedical sensors
Kruss, S., Hilmer, A. J., Zhang, J., Reuel, N. F., Mu, B., & Strano, M. S. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.015 · Cited by 418
Cardiac Troponin Assays: Guide to Understanding Analytical Characteristics and Their Impact on Clinical Care
Apple, F. S., Sandoval, Y., Jaffe, A. S., & Ordonez-Llanos, J. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.255109 · Cited by 408
Self-citation
High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial
Shah, A. S. V., Anand, A., Strachan, F. E., Ferry, A. V., Lee, K. K., Chapman, A. R., Sandeman, D., Stables, C. L., Adamson, P. D., Andrews, J. P. M., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31923-8 · Cited by 405
Self-citation
Age- and Sex-Dependent Upper Reference Limits for the High-Sensitivity Cardiac Troponin T Assay
Gore, M. O., Seliger, S. L., deFilippi, C. R., Nambi, V., Christenson, R. H., Hashim, I. A., Hoogeveen, R. C., Ayers, C. R., Sun, W., McGuire, D. K., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.12.032 · Cited by 372
Role of Serum Biomarkers in Cancer Patients Receiving Cardiotoxic Cancer Therapies: A Position Statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology
Pudil, R., Mueller, C. E., Čelutkienė, J., Henriksen, P. A., Lenihan, D. J., Dent, S. F., Barac, A., Stanway, S., Moslehi, J. J., Suter, T. M., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.2017 · Cited by 382
Validation of High-Sensitivity Troponin I in a 2-Hour Diagnostic Strategy to Assess 30-Day Outcomes in Emergency Department Patients With Possible Acute Coronary Syndrome
Cullen, L., Mueller, C. E., Parsonage, W. A., Wildi, K. S., Greenslade, J. H., Twerenbold, R., Aldous, S. J., Meller, B., Tate, J. R., Reichlin, T., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.078 · Cited by 315
High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants
Willeit, P., Welsh, P. I., Evans, J. D. W., Tschiderer, L., Boachie, C., Jukema, J. W., Ford, I., Trompet, S., Stott, D. J., Kearney, P. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.05.062 · Cited by 298
IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays
Apple, F. S., Jaffe, A. S., Collinson, P. O., Möckel, M. M., Ordóñez‐Llanos, J., Lindahl, B., Hollander, J. E., Plebani, M., Than, M. P., & Chan, M. H. M. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.08.021 · Cited by 287
Self-citation
Assessment and classification of patients with myocardial injury and infarction in clinical practice
Chapman, A. R., Adamson, P. D., & Mills, N. L. (2016) · Heart · doi:10.1136/heartjnl-2016-309530 · Cited by 253
Cardiac troponin level elevations not related to acute coronary syndromes
Giannitsis, E., & Katus, H. A. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.129 · Cited by 243
Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trials
Jobs, A., Mehta, S. R., Montalescot, G., Vicaut, É., Hof, A. W. J. V. ’., Badings, E., Neumann, F., Kastrati, A., Sciahbasi, A., Reuter, P., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31490-3 · Cited by 235
High-sensitivity assays for troponin in patients with cardiac disease
Westermann, D., Neumann, J. T., Sörensen, N. A., & Blankenberg, S. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.48 · Cited by 222
Are There Deleterious Cardiac Effects of Acute and Chronic Endurance Exercise?
Eijsvogels, T. M. H., Fernández, A. B., & Thompson, P. D. (2015) · Physiological Reviews · doi:10.1152/physrev.00029.2014 · Cited by 236
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure
Aimo, A., Januzzi, J. L., Vergaro, G., Ripoli, A., Latini, R., Masson, S., Magnoli, M., Anand, I. S., Cohn, J. N., Tavazzi, L., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.031560 · Cited by 231
Unstable Angina: Is It Time for a Requiem?
Braunwald, E., & Morrow, D. A. (2013) · Circulation · doi:10.1161/circulationaha.113.001258 · Cited by 226
High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study
Jia, X., Sun, W., Hoogeveen, R. C., Nambi, V., Matsushita, K., Folsom, A. R., HEISS, G. M., Couper, D. J., Solomon, S. D., Boerwinkle, E., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.038772 · Cited by 223
High-Sensitivity Cardiac Troponin and the Universal Definition of Myocardial Infarction
Chapman, A. R., Adamson, P. D., Shah, A. S. V., Anand, A., Strachan, F. E., Ferry, A. V., Lee, K. K., Berry, C., Findlay, I. N., Cruikshank, A., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.042960 · Cited by 220
Self-citation
Rapid upregulation and clearance of distinct circulating microRNAs after prolonged aerobic exercise
Baggish, A. L., Park, J., Min, P., Isaacs, S. K., Parker, B. A., Thompson, P. D., Troyanos, C., d’Hemecourt, P. A., Dyer, S., Thiel, M., et al. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01141.2013 · Cited by 210
An historical approach to the diagnostic biomarkers of acute coronary syndrome
Danese, E., & Montagnana, M. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.05.19 · Cited by 218
Recent advances in the diagnosis and treatment of acute myocardial infarction
Reddy, K. R. (2015) · World Journal of Cardiology · doi:10.4330/wjc.v7.i5.243 · Cited by 199
Diagnostic accuracy of single baseline measurement of Elecsys Troponin T high-sensitive assay for diagnosis of acute myocardial infarction in emergency department: systematic review and meta-analysis
Zhelev, Z., Hyde, C., Youngman, E., Rogers, M., Fleming, S., Slade, T., Coelho, H. F., Jones-Hughes, T., & Nikolaou, V. (2015) · BMJ · doi:10.1136/bmj.h15 · Cited by 199
Point-of-care testing (POCT) and evidence-based laboratory medicine (EBLM) – does it leverage any advantage in clinical decision making?
Florkowski, C., Don-Wauchope, A., Gimenez, N., Rodriguez-Capote, K., Wils, J., & Zemlin, A. (2017) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2017.1399336 · Cited by 189
Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association ( HFA ), European Society of Cardiology ( ESC )
Meijers, W. C., Bayés‐Genís, A., Mebazaa, A., Bauersachs, J. K., Cleland, J. G. F., Coats, A. J. S., Januzzi, J. L., Maisel, A. S., McDonald, K., Mueller, T., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2346 · Cited by 206
High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Controlled Trial
Anand, A., Lee, K. K., Chapman, A. R., Ferry, A. V., Adamson, P. D., Strachan, F. E., Berry, C., Findlay, I. N., Cruikshank, A., Reid, A., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.052380 · Cited by 184
Self-citation
High-sensitivity cardiac troponin T in prediction and diagnosis of myocardial infarction and long-term mortality after noncardiac surgery
Nägele, P., Brown, F., Gage, B. F., Gibson, D. W., Miller, J. P., Jaffe, A. S., Apple, F. S., & Scott, M. G. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.04.018 · Cited by 173
Self-citation
Cardiac Troponins in Dogs and Cats
Langhorn, R., & Willesen, J. L. (2015) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.13801 · Cited by 178
High-sensitivity troponin assays for the early rule-out or diagnosis of acute myocardial infarction in people with acute chest pain: a systematic review and cost-effectiveness analysis
Westwood, M. E., van Asselt, A. D. I., Ramaekers, B. L. T., Whiting, P. F., Thokala, P., Joore, M. A., Armstrong, N., Ross, J., Severens, J. L., & Kleijnen, J. (2015) · Health Technology Assessment · doi:10.3310/hta19440 · Cited by 163
The Global Need to Define Normality: The 99th Percentile Value of Cardiac Troponin
Sandoval, Y. B., & Apple, F. S. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.211706 · Cited by 161
Self-citation
Biosensors as diagnostic tools in clinical applications
Lino, C., Barrias, S., Chaves, R., Adega, F., Martins‐Lopes, P., & Fernandes, J. R. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188726 · Cited by 175
European multicenter analytical evaluation of the Abbott ARCHITECT STAT high sensitive troponin I immunoassay
Krintus, M., Koziński, M., Boudry, P., Capell, N. E., Köller, U., Lackner, K. J., Lefèvre, G., Lennartz, L., Lotz, J., Mora-Herranz, A., et al. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-0107 · Cited by 154
Sensitive Troponin Assay and the Classification of Myocardial Infarction
Shah, A. S. V., McAllister, D., Mills, R., Lee, K. K., Churchhouse, A. M. D., Fleming, K., Layden, E., Anand, A., Fersia, O., Joshi, N. V., et al. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.10.056 · Cited by 154
Novel Risk Markers and Risk Assessments for Cardiovascular Disease
Thomas, M. R., & Lip, G. Y. H. (2017) · Circulation Research · doi:10.1161/circresaha.116.309955 · Cited by 157
Comparison between High-Sensitivity Cardiac Troponin T and Cardiac Troponin I in a Large General Population Cohort
Welsh, P. I., Preiss, D., Shah, A. S. V., McAllister, D., Briggs, A. H., Boachie, C., McConnachie, A., Hayward, C., Padmanabhan, S., Welsh, C. E., et al. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2018.292086 · Cited by 150
Misdiagnosis of Myocardial Infarction Related to Limitations of the Current Regulatory Approach to Define Clinical Decision Values for Cardiac Troponin
Wildi, K. S., Giménez, M. R., Twerenbold, R., Reichlin, T., Jaeger, C., Heinzelmann, A., Arnold, C., Nelles, B., Druey, S., Haaf, P., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.014129 · Cited by 142
Defining High-Sensitivity Cardiac Troponin Concentrations in the Community
McKie, P. M., Heublein, D. M., Scott, C. G., Gantzer, M. L., Mehta, R. A., Rodeheffer, R. J., Redfield, M. M., Burnett, J. C. J., & Jaffe, A. S. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.198614 · Cited by 142
Preparing the United States for High-Sensitivity Cardiac Troponin Assays
Korley, F. K., & Jaffe, A. S. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.069 · Cited by 142
Exercise-Induced Cardiac Troponin Elevations: From Underlying Mechanisms to Clinical Relevance
Aengevaeren, V. L., Baggish, A. L., Chung, E. H., George, K., Kleiven, Ø., Mingels, A. M. A., Ørn, S., Shave, R., Thompson, P. D., & Eijsvogels, T. M. H. (2021) · Circulation · doi:10.1161/circulationaha.121.056208 · Cited by 150
High sensitivity cardiac troponin assays in the clinical laboratories
Jarolı́m, P. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-0565 · Cited by 138
High‐Sensitivity Troponin Assays: Evidence, Indications, and Reasonable Use
Sherwood, M. W., & Newby, L. K. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000403 · Cited by 145
Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome
Lee, K. K., Ferry, A. V., Anand, A., Strachan, F. E., Chapman, A. R., Kimenai, D. M., Meex, S. J. R., Berry, C., Findlay, I. N., Reid, A. W., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.07.082 · Cited by 138
Self-citation
COLIN trial: Value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response
Akodad, M., Lattuca, B., Nagot, N., Georgescu, V., Buisson, M., Cristol, J., Leclercq, F., Macia, J., Gervasoni, R., Cung, T.-T., et al. (2017) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2016.10.004 · Cited by 130
Exercise-Induced Cardiac Troponin I Increase and Incident Mortality and Cardiovascular Events
Aengevaeren, V. L., Hopman, M. T. E., Thompson, P. D., Bakker, E. A., George, K., Thijssen, D. H. J., & Eijsvogels, T. M. H. (2019) · Circulation · doi:10.1161/circulationaha.119.041627 · Cited by 133
Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity
Christenson, E. S., James, T., Agrawal, V., & Park, B. H. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.10.013 · Cited by 125
Diagnostic and prognostic implications using age- and gender-specific cut-offs for high-sensitivity cardiac troponin T — Sub-analysis from the TRAPID-AMI study
Mueller‐Hennessen, M., Lindahl, B., Giannitsis, E., Biener, M., Vafaie, M., deFilippi, C. R., Christ, M., Santaló, M., Panteghini, M., Plebani, M., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.01.213 · Cited by 122
High-Sensitivity Cardiac Troponin T Concentrations below the Limit of Detection to Exclude Acute Myocardial Infarction: A Prospective Evaluation
Body, R. M., Burrows, G., Carley, S. D., Cullen, L., Than, M. P., Jaffe, A. S., & Lewis, P. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.231530 · Cited by 114
High-Sensitivity Troponin T and Mortality After Elective Percutaneous Coronary Intervention
Ndrepepa, G., Colleran, R., Braun, S., Cassese, S., Hieber, J., Fusaro, M., Kufner, S., Ott, I., Byrne, R. A., Hüsser, O., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.08.059 · Cited by 113
One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I
Jaeger, C., Wildi, K. S., Twerenbold, R., Reichlin, T., Giménez, M. R., Neuhaus, J. D., Grimm, K., Boeddinghaus, J., Hillinger, P., Nestelberger, T., et al. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.07.022 · Cited by 113
Novel Biomarkers of Heart Failure
Savic-Radojevic, A. R., Pljesa-Ercegovac, M. S., Matic, M., Simic, D., Radovanović, S., & Simic, T. P. (2016) · Advances in clinical chemistry · doi:10.1016/bs.acc.2016.09.002 · Cited by 113
High-Sensitivity Cardiac Troponin and the Risk Stratification of Patients With Renal Impairment Presenting With Suspected Acute Coronary Syndrome
Miller-Hodges, E. V., Anand, A., Shah, A. S. V., Chapman, A. R., Gallacher, P. J., Lee, K. K., Farrah, T. E., Halbesma, N., Blackmur, J. P., Newby, D. E., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.030320 · Cited by 114
Impact of Sex on the Prognostic Value of High-Sensitivity Cardiac Troponin I in the General Population: The HUNT Study
Omland, T., de Lemos, J. A., Holmen, O. L., Dalen, H., Benth, J. Š., Nygård, S., Hveem, K., & Røsjø, H. R. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.234369 · Cited by 111
High-Sensitivity Cardiac Troponin T Levels and Secondary Events in Outpatients With Coronary Heart Disease From the Heart and Soul Study
Beatty, A. L., Ku, I. A., Christenson, R. H., deFilippi, C. R., Schiller, N. B., & Whooley, M. A. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.116 · Cited by 108
High-Sensitivity Troponin and the Application of Risk Stratification Thresholds in Patients With Suspected Acute Coronary Syndrome
Bularga, A., Lee, K. K., Stewart, S. D., Ferry, A. V., Chapman, A. R., Marshall, L., Strachan, F. E., Cruickshank, A., Maguire, D., Berry, C., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.042866 · Cited by 107
A plug-and-play platform of ratiometric bioluminescent sensors for homogeneous immunoassays
Ni, Y., Rosier, B. J. H. M., van Aalen, E. A., Hanckmann, E. T. L., Biewenga, L., Pistikou, A. M., Timmermans, B. J. R., Vu, C., Roos, S., Arts, R., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24874-3 · Cited by 113
Clinical Effect of Sex-Specific Cutoff Values of High-Sensitivity Cardiac Troponin T in Suspected Myocardial Infarction
Giménez, M. R., Twerenbold, R., Boeddinghaus, J., Nestelberger, T., Puelacher, C., Hillinger, P., Wildi, K. S., Jaeger, C., Grimm, K., Heitzelmann, K.-F., et al. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.2882 · Cited by 102
Synaptophysin and neurofilament proteins as markers for neuroendocrine tumors.
Miettinen, M. (1987) · PubMed · Cited by 100
Comparison of conventional and high-sensitivity troponin in patients with chest pain: A collaborative meta-analysis
Lipinski, M. J., Baker, N. C., Escarcega, R. O., Torguson, R., Chen, F., Aldous, S. J., Christ, M., Collinson, P. O., Goodacre, S. W., Mair, J. M., et al. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.10.007 · Cited by 102
Self-citation
High-Sensitivity Troponin: A Review on Characteristics, Assessment, and Clinical Implications
Lazar, D. R., Lazăr, F.-L., Homorodean, C., Cainap, C. I., Focşan, M., Cainap, S. S., & Olinic, D.-M. (2022) · Disease Markers · doi:10.1155/2022/9713326 · Cited by 113
High incidence of macrotroponin I with a high-sensitivity troponin I assay
Warner, J., & Marshall, G. A. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2015-1276 · Cited by 99
Weekly and 90-Minute Biological Variations in Cardiac Troponin T and Cardiac Troponin I in Hemodialysis Patients and Healthy Controls
Aakre, K. M., Røraas, T., Petersen, P. H., Svarstad, E., Sellevoll, H., Skadberg, Ø., Sæle, K., & Sandberg, S. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2013.216978 · Cited by 97
What to do when you question cardiac troponin values
Mair, J. M., Lindahl, B., Mueller, C. E., Giannitsis, E., Huber, K., Möckel, M. M., Plebani, M., Thygesen, K. A., & Jaffe, A. S. (2017) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872617708973 · Cited by 94
The Prognostic Value of Highly Sensitive Cardiac Troponin Assays for Adverse Events in Men and Women with Stable Heart Failure and a Preserved vs. Reduced Ejection Fraction
Gohar, A., Chong, J. P. C., Liew, O. W., den Ruijter, H. M., de Kleijn, D. P. V., Sim, D., Yeo, D., Ong, H. Y., Jaufeerally, F. R., Leong, G. K. T., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.911 · Cited by 98
Clinical Policy: Critical Issues in the Evaluation and Management of Emergency Department Patients With Suspected Non–ST-Elevation Acute Coronary Syndromes
Brown, M. D., Wolf, S. J., Byyny, R. L., Diercks, D. B., Gemme, S. R., Gerardo, C. J., Godwin, S. A., Hahn, S. A., Harrison, N. E., Hatten, B. W., et al. (2018) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2018.07.045 · Cited by 97
Elevated Plasma Cardiac Troponin T Levels Caused by Skeletal Muscle Damage in Pompe Disease
Wens, S. C. A., Schaaf, G., Michels, M., Kruijshaar, M. E., van Gestel, T. J. M., Groen, S. L. M. I. ‘., Pijnenburg, J., Dekkers, D. H. W., Demmers, J., Verdijk, L. B., et al. (2016) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.115.001322 · Cited by 93
Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study
Gulati, G., Heck, S. L., Røsjø, H. R., Ree, A. H., Hoffmann, P., Hagve, T., Norseth, J., Gravdehaug, B., Steine, K., Geisler, J., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006513 · Cited by 93
Temporal Release of High-Sensitivity Cardiac Troponin T and I and Copeptin After Brief Induced Coronary Artery Balloon Occlusion in Humans
Árnadóttir, Á., Pedersen, S. H., Hasselbalch, R. B., Goetze, J. P., Friis-Hansen, L. J., Münster, A. B., Jensen, J. S., Bundgaard, H., & Iversen, K. K. (2020) · Circulation · doi:10.1161/circulationaha.120.046574 · Cited by 93
A Rapid, Direct, Quantitative, and Label‐Free Detector of Cardiac Biomarker Troponin T Using Near‐Infrared Fluorescent Single‐Walled Carbon Nanotube Sensors
Zhang, J., Kruss, S., Hilmer, A. J., Shimizu, S. F. E., Schmois, Z., Cruz, F. D. L., Barone, P. W., Reuel, N. F., Heller, D. A., & Strano, M. S. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201300033 · Cited by 94
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy
Franzini, M., Lorenzoni, V., Masotti, S., Prontera, C., Chiappino, D., Latta, D. D., Daves, M., Deluggi, I., Zuin, M. G., Ferrigno, L., et al. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.09.010 · Cited by 92
The 99th percentile of reference population for cTnI and cTnT assay: methodology, pathophysiology and clinical implications
Clerico, A., Zaninotto, M., Ripoli, A., Masotti, S., Prontera, C., Passino, C., & Plebani, M. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0933 · Cited by 91
Relative Prognostic Value of Cardiac Troponin I and C-Reactive Protein in the General Population (from the Nord-Trøndelag Health [HUNT] Study)
Sigurdardottir, F. D., Lyngbakken, M. N., Holmen, O. L., Dalen, H., Hveem, K., Røsjø, H. R., & Omland, T. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.01.004 · Cited by 94
Role of Cardiac Troponin Levels in Acute Heart Failure
Wettersten, N. W., Maisel, A. S., & Veterans Affairs San Diego Healthcare System, L. J. (2015) · Cardiac failure review · doi:10.15420/cfr.2015.1.2.102 · Cited by 90
Diagnostic and prognostic value of biomarkers in acute myocardial infarction
Chen, Y., Tao, Y., Zhang, L., Xu, W., & Zhou, X. (2019) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2019-136409 · Cited by 89
A Review On Zno-Based Electrical Biosensors for Cardiac Biomarker Detection
Shanmugam, N. R., Muthukumar, S., & Prasad, S. (2017) · Future Science OA · doi:10.4155/fsoa-2017-0006 · Cited by 88
Variability and Error in Cardiac Troponin Testing
Herman, D. S., Kavsak, P. A., & Greene, D. N. (2017) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqx066 · Cited by 87
Prognostic value of basal high-sensitive cardiac troponin levels on mortality in the general population
van der Linden, N., Klinkenberg, L. J. J., Bekers, O., van Loon, L. J. C., van Dieijen‐Visser, M. P., Zeegers, M. P., & Meex, S. J. R. (2016) · Medicine · doi:10.1097/md.0000000000005703 · Cited by 86
Heart-type fatty acid-binding protein in the early diagnosis of acute myocardial infarction
Reiter, M., Twerenbold, R., Reichlin, T., Mueller, M., Hoeller, R., Moehring, B., Haaf, P., Wildi, K. S., Merk, S., Bernhard, D., et al. (2013) · Heart · doi:10.1136/heartjnl-2012-303325 · Cited by 84
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides
Clerico, A., Passino, C., Franzini, M., & Emdin, M. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.06.003 · Cited by 83
Short- and Long-term Biologic Variability of Galectin-3 and Other Cardiac Biomarkers in Patients with Stable Heart Failure and Healthy Adults
Schindler, E. I., Szymanski, J. J., Hock, K. G., Geltman, E. M., & Scott, M. G. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.246553 · Cited by 83
Direct comparison of clinical decision limits for cardiac troponin T and I
Kimenai, D. M., Henry, R. M. A., Kallen, C., Dagnelie, P. C., Schram, M. T., Stehouwer, C. D. A., van Suijlen, J. D. E., Niens, M., Bekers, O., Sep, S. J. S., et al. (2016) · Heart · doi:10.1136/heartjnl-2015-308917 · Cited by 83
Prognostic Performance of a High-Sensitivity Cardiac Troponin I Assay in Patients with Non–ST-Elevation Acute Coronary Syndrome
Bohula, E. A., Bonaca, M. P., Jarolı́m, P., Antman, E. M., D, E. B. M., Giugliano, R. P., Newby, L. K., Sabatine, M. S., & Morrow, D. A. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.206441 · Cited by 80
Paper/Soluble Polymer Hybrid-Based Lateral Flow Biosensing Platform for High-Performance Point-of-Care Testing
Han, G., Koo, H. J., Ki, H., & Kim, M. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c07893 · Cited by 80
Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum
Tiambeng, T. N., Roberts, D. S., Brown, K. A., Zhu, Y., Chen, B., Wu, Z., Mitchell, S. D., Guardado-Alvarez, T. M., Jin, S., & Ge, Y. (2020) · Nature Communications · doi:10.1038/s41467-020-17643-1 · Cited by 76
Limit of detection of troponin discharge strategy versus usual care: randomised controlled trial
Carlton, E. W., Ingram, J. C., Taylor, H., Glynn, J., Kandiyali, R., Campbell, S., Beasant, L., Aziz, S., Beresford, P., Kendall, J., et al. (2020) · Heart · doi:10.1136/heartjnl-2020-316692 · Cited by 79
High-Sensitivity Cardiac Troponin and New-Onset Heart Failure
Evans, J. D. W., Dobbin, S. J. H., Pettit, S., Angelantonio, E. D., & Willeit, P. (2018) · JACC Heart Failure · doi:10.1016/j.jchf.2017.11.003 · Cited by 85
Biomarkers for Heart Failure: An Update for Practitioners of Internal Medicine
Wettersten, N. W., & Maisel, A. S. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.01.013 · Cited by 78
The Use of Very Low Concentrations of High‐sensitivity Troponin T to Rule Out Acute Myocardial Infarction Using a Single Blood Test
Body, R. M., Mueller, C. E., Giannitsis, E., Christ, M., Ordóñez‐Llanos, J., de Filippi, C. R., Nowak, R. M., Panteghini, M., Jernberg, T., Plebani, M., et al. (2016) · Academic Emergency Medicine · doi:10.1111/acem.13012 · Cited by 78
High-sensitivity troponin assays for early rule-out of acute myocardial infarction in people with acute chest pain: a systematic review and economic evaluation
Westwood, M. E., Ramaekers, B. L. T., Grimm, S. E., Worthy, G., Fayter, D., Armstrong, N., Buksnys, T., Ross, J., Joore, M. A., & Kleijnen, J. (2021) · Health Technology Assessment · doi:10.3310/hta25330 · Cited by 87
Present and Future of Cardiac Troponin in Clinical Practice: A Paradigm Shift to High-Sensitivity Assays
Sandoval, Y. B., Smith, S. W., & Apple, F. S. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.12.005 · Cited by 77
Self-citation
Comparison of Cardiac Troponin I and T, Including the Evaluation of an Ultrasensitive Assay, as Indicators of Doxorubicin-induced Cardiotoxicity
Reagan, W. J., York, M. J., Berridge, B. R., Schultze, E., Walker, D. B., & Pettit, S. D. (2013) · Toxicologic Pathology · doi:10.1177/0192623313482056 · Cited by 77

Authors: Apple, F. S., Collinson, P. O., & for the IFCC Task Force on Clinical Applications of Cardiac Biomarkers
Affiliations: University of Minnesota (US)
St George's Hospital (GB)
Corresponding author: Apple, Fred S
ORCID: Apple, Fred S
Collinson, Paul O
Venue: Clinical Chemistry
Publisher: Oxford University Press (OUP)
Published: 2012-01-01
Volume: 58
Issue: 1
Pages: 54-61
ISSN: 0009-9147 (ISSN-L)
1530-8561
DOI: 10.1373/clinchem.2011.165795
OpenAlex: W2151231511
Cited by: 861
References: 41
Citations by year: 2026: 26 · 2025: 39 · 2024: 33 · 2023: 42 · 2022: 44 · 2021: 51 · 2020: 53 · 2019: 58 · 2018: 63 · 2017: 87 · 2016: 88 · 2015: 69 · 2014: 75 · 2013: 81 · 2012: 46
FWCI: 11.14
Type: journal article
Language: en
Open access: closed
Licence: academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
Locations: Clinical Chemistry (publishedVersion)
PubMed (publishedVersion)
Funders: Siemens
Abbott
Radiometer
B.R.A.H.M.S.
Roche
Alere
Instrumentation Laboratories
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
Keywords: high-sensitivity troponin I, high-sensitivity troponin T, cardiac troponin assays, assay standardization, reference limits, biological variation, assay imprecision, myocardial injury biomarkers, acute coronary syndrome, myocardial infarction diagnosis
MeSH terms: Humans, Immunoassay, Myocardial Infarction, Myocardium, Reference Values, Sensitivity and Specificity, Biomarkers, Troponin I, Troponin T, Acute Coronary Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Analytical Characteristics of High-Sensitivity Cardiac Troponin Assays

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks